MedTrace Logo

Developing an Activity Pacing Framework: Feasibility and Acceptability

NCT03497585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2020-12-17

Study results available
· View outcomes & findings →

Summary

This study explores whether it is feasible to use a newly developed activity pacing framework to standardise how activity pacing is instructed by healthcare professionals in rehabilitation programmes for patients with chronic pain/fatigue.

Conditions

  • Chronic Pain
  • Fibromyalgia
  • Chronic Fatigue Syndrome
  • Chronic Low Back Pain

Interventions

BEHAVIORAL

Activity pacing framework

The activity pacing framework will be used to structure and standardise the instructions of pacing in existing rehabilitation programmes for adult patients with chronic pain/fatigue. The activity pacing framework has been developed in Stages I and II of this research. Stage I involved an online survey of activity pacing across healthcare professionals in England. The survey findings, together with existing research were used to develop the first draft of the framework. The framework was refined in Stage II: Nominal group technique (consensus method). The activity pacing framework describes the aims, facets and stages of pacing, together with how pacing relates to different behavioural typologies and other pain management strategies.

Sponsors & Collaborators

  • University of Leeds

    collaborator OTHER

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Pennine Acute Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Deborah Antcliff, PhD, BSc · Pennine Acute Hospitals NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-21
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03497585 on ClinicalTrials.gov